Dynamics of KRAS G12/13 allele burden in circulating tumor DNA predicts survival in patients with unresectable pancreatic cancer undergoing palliative chemotherapy

被引：0
|
作者：
Johansen, J. S. [1 ]
Vibat, C. R. T. [2 ]
Hancock, S. [2 ]
Chen, I. [1 ]
Samuelsz, E. [2 ]
Collisson, E. A. [3 ]
Jensen, B. V. [1 ]
Melnikova, V. [2 ]
Erlander, M. G. [2 ]
机构：
[1] Herlev Hosp, Onkol Afd R, DK-2730 Herlev, Denmark
[2] Trovagene, Res & Dev, San Diego, CA USA
[3] Univ Calif San Francisco, Dept Oncol, San Francisco, CA 94143 USA
来源：
EUROPEAN JOURNAL OF CANCER | 2015年 / 51卷
关键词：
D O I：
10.1016/S0959-8049(16)31317-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2401
引用
收藏
页码：S470 / S471
页数：2
相关论文
共 22 条
  • [1] Quantitative monitoring of circulating tumor DNA in patients with advanced pancreatic cancer undergoing chemotherapy
    Sugimori, Makoto
    Sugimori, Kazuya
    Tsuchiya, Hiromi
    Suzuki, Yoshimasa
    Tsuyuki, Sho
    Kaneta, Yoshihiro
    Hirotani, Akane
    Sanga, Katsuyuki
    Tozuka, Yuichiro
    Komiyama, Satoshi
    Sato, Takeshi
    Tezuka, Shun
    Goda, Yoshihiro
    Irie, Kuniyasu
    Miwa, Haruo
    Miura, Yuuki
    Ishii, Tomohiro
    Kaneko, Takashi
    Nagahama, Masatsugu
    Shibata, Wataru
    Nozaki, Akito
    Maeda, Shin
    CANCER SCIENCE, 2020, 111 (01) : 266 - 278
  • [2] Mutant KRAS in Circulating Tumor DNA Assessed by Digit Droplet PCR as a Biomarker in Pancreatic Cancer in Patients Treated with Neoadjuvant Chemotherapy
    Vitello, Dominic
    Shah, Dhavan
    Wells, Amy
    Masnyk, Larissa
    Cox, Madison
    Janczewski, Lauren
    Abad, John
    Dawravoo, Kevin
    D'Souza, Arlene
    Suh, Grace
    Bayer, Robert
    Cristofanilli, Massimo
    Bentrem, David
    Liu, Yingzhe
    Zhang, Hui
    Santana-Santos, Lucas
    Jennings, Lawrence
    Zhang, Qiang
    Chawla, Akhil
    CANCER RESEARCH, 2024, 84 (17)
  • [3] Comparative levels of KRAS mutations circulating tumor DNA for association with overall survival in patients with non-resectable pancreatic cancer
    Johansen, Julia S.
    Vibat, Cecile Rose T.
    Hancock, Saege
    Hassaine, Latifa
    Samuelsz, Errin
    Chen, Inna
    Collisson, Eric A.
    Calatayud, Dan
    Jensen, Benny V.
    Hasselby, Jane Preuss
    Lu, Timothy T.
    Poole, Jason C.
    Melnikova, Vlada
    Erlander, Mark G.
    CANCER RESEARCH, 2015, 75
  • [4] Circulating Tumor DNA Dynamics and Clinical Outcome in Metastatic Colorectal Cancer Patients Undergoing Front-Line Chemotherapy
    Ghidini, Michele
    Hahne, Jens Claus
    Senti, Chiara
    Heide, Timon
    Proszek, Paula Z.
    Shaikh, Ridwan
    Carter, Paul
    Hubank, Mike
    Trevisani, Francesco
    Garrone, Ornella
    Cappelletti, Maria Rosa
    Generali, Daniele
    Cattaneo, Monica
    Gnocchi, Nicoletta
    Donati, Gianvito
    Gobbi, Angela
    Grizzi, Giulia
    Lampis, Andrea
    Elghadi, Raghad
    Tanzi, Giulia
    Tomasello, Gianluca
    Ratti, Margherita
    Pinato, David J.
    Fassan, Matteo
    Vlachogiannis, Georgios
    Sottoriva, Andrea
    Cortellini, Alessio
    Passalacqua, Rodolfo
    Valeri, Nicola
    CLINICAL CANCER RESEARCH, 2025, 31 (04) : 707 - 718
  • [5] Prognostic value of plasma circulating tumor (ct) DNA KRAS mutations and serum CA19-9 in unresectable pancreatic cancer (PC) patients
    Johansen, Julia S.
    Vibat, Cecile Rose T.
    Hancock, Saege
    Chen, Inna Markovna
    Hassaine, Latifa
    Samuelsz, Errin
    Collisson, Eric Andrew
    Jensen, Benny Vittrup
    Lu, Timothy T.
    Melnikova, Vlada
    Erlander, Mark G.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [6] Higher mutation burden and mutant allele fraction of circulating tumor DNA corresponds to worse progression free survival in metastatic breast cancer patients
    Keenan, Tanya
    Juric, Dejan
    Niemierko, Andrzej
    Spring, Laura
    Park, Hannah
    Malvarosa, Giuliana
    Beeler, Maureen
    Moy, Beverly
    Ellisen, Leif
    Isakoff, Steven
    Bardia, Aditya
    CANCER RESEARCH, 2018, 78 (04)
  • [7] Circulating tumor DNA (ctDNA) dynamics and clinical outcome in metastatic colorectal cancer (mCRC) patients (pts) undergoing front-line chemotherapy
    Ghidini, M.
    Hahne, J. C.
    Senti, C.
    Tomasello, G.
    Ratti, M.
    Heide, T.
    Garrone, O.
    Cortellini, A.
    Passalacqua, R.
    Valeri, N.
    ANNALS OF ONCOLOGY, 2023, 34 : S1188 - S1188
  • [8] Dynamics of circulating tumor DNA during postoperative radiotherapy for triple-negative breast cancer in patients undergoing neoadjuvant chemotherapy and breast surgery
    Kim, H.
    Kim, Y. J.
    Park, D.
    Park, W. -Y.
    Choi, D. H.
    Park, W.
    Cho, W. K.
    BREAST, 2021, 56 : S48 - S48
  • [9] Detection of KRAS G12/G13 Mutations in Cell Free-DNA by Droplet Digital PCR, Offers Prognostic Information for Patients with Advanced Non-Small Cell Lung Cancer
    Michaelidou, Kleita
    Koutoulaki, Chara
    Mavridis, Konstantinos
    Vorrias, Eleftherios
    Papadaki, Maria A.
    Koutsopoulos, Anastasios V.
    Mavroudis, Dimitrios
    Agelaki, Sofia
    CELLS, 2020, 9 (11)
  • [10] Circulating tumor DNA (ctDNA) dynamics and clinical outcome in metastatic colorectal cancer (mCRC) patients (pts) undergoing front-line chemotherapy.
    Ghidini, Michele
    Hahne, Jens Claus
    Senti, Chiara
    Tomasello, Gianluca
    Ratti, Margherita
    Heide, Timon
    Garrone, Ornella
    Cortellini, Alessio
    Passalacqua, Rodolfo
    Valeri, Nicola
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 175 - 175
123